Research · Sep 3, 2026
NEO: FY25 Deep Dive
NeoGenomics FY25 at $727M. NI $-108M; EPS $-4.20. Diagnostics.
NEO
NeoGenomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.38
−0.46%NASDAQ · Healthcare · Medical - Diagnostics & Research · US
Research · Sep 3, 2026
NeoGenomics FY25 at $727M. NI $-108M; EPS $-4.20. Diagnostics.